Quantum Corp: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Nov 13, 2025 and accepted by EDGAR at Nov 13, 2025, 17:07 ET.
Management's discussion and analysis
As filed, 31,114 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis compares the change in the consolidated financial statements for quarters and six months ended September 30, 2025 and September 30, 2024, and should be read together with our condensed consolidated financial statements and the related notes thereto included in this Quarterly Report on Form 10-Q, and the audited consolidated financial statements and notes thereto and management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “Annual Report”). In particular, the risk factors contained in Part I, Item 1A of the Annual Report under the heading “Risk Factors” may reflect trends, demands, commitments, events, or uncertainties that could materially impact our results of operations and liquidity and capital resources. For comparisons of quarters and six months ended September 30, 2024 and September 30, 2023, see our Management's Discussion and Analysis of Financial Condition and Results of Operations in Item 2 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November 14, 2024, and incorporated herein by reference. Our fiscal year ends on March 31 of each calendar year. "Fiscal 2025" refers to the fiscal year ended March 31, 2025.
The following discussion contains forward-looking statements, such as statements regarding anticipated impacts on our business, our future operating results and financial position, our business strategy and plans, our market growth and trends, and our objectives for future operations. Please see "Note Regarding Forward-Looking Statements" for more information about relying on these forward-looking statements.
OVERVIEW
We are a technology company whose mission is to deliver innovative solutions to organizations across the world. We design, manufacture and sell technology and services that help customers capture, create and share digital content, and protect it for decades. We emphasize innovative technology in the design and manufacture of our products to help our customers unlock the value in their video and unstructured data in new ways to solve their most pressing business challenges.
We generate revenue by designing, manufacturing, and selling technology and services. Our most significant expenses are related to compensating employees; designing, manufacturing, marketing, and selling our products and services; data center costs in support of our cloud-based services; and interest associated with our long-term debt and income taxes.
Macroeconomic Conditions
We continue to actively monitor, evaluate and respond to the current uncertain macro environment, including the impact of changing interest rates, inflation, tariffs, lingering supply chain challenges, and fluctuation in the U.S. dollar. During the quarter we continued to experience longer sales cycle for opportunities with our enterprise as well as commercial customers.
The macro environment remains unpredictable and our past results may not be indicative of future performance.
RESULTS OF OPERATIONS
(in thousands)
| Three Months Ended September 30, 2025 | 2024 | Six Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Total revenue | $62,715 | $71,846 | $127,002 | $144,111 |
| Total cost of revenue (1) | 39,163 | 41,201 | 80,736 | 86,410 |
| Gross profit | 23,552 | 30,645 | 46,266 | 57,701 |
| Operating expenses | ||||
| Sales and marketing (1) | 11,819 | 13,578 | 24,474 | 26,873 |
| General and administrative (1) | 11,006 | 13,977 | 24,576 | 35,042 |
| Research and development (1) | 5,692 | 8,264 | 12,353 | 16,572 |
| Restructuring charges (1) | 3,193 | 383 | 5,616 | 1,574 |
| Total operating expenses | 31,710 | 36,202 | 67,019 | 80,061 |
| Loss from operations | (8,158) | (5,557) | (20,753) | (22,360) |
| Other income (expense), net | (185) | (1,334) | (616) | (1,375) |
| Interest expense | (6,227) | (6,131) | (12,743) | (9,921) |
| Change in fair value of warrant liabilities | 1,525 | 3,550 | 1,525 | 5,216 |
| Loss on debt extinguishment | (33,254) | (2,308) | (30,695) | (3,003) |
| Loss before income taxes | (46,299) | (11,780) | (63,282) | (31,443) |
| Income tax provision | 157 | 370 | 380 | 605 |
| Net loss | $(46,456) | $(12,150) | $(63,662) | $(32,048) |
(1) Includes stock-based compensation as follows:
(in thousands)
| Three Months Ended September 30, 2025 | 2024 | Six Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Cost of revenue | $41 | $76 | $(567) | $266 |
| Research and development | 19 | 161 | 87 | 349 |
| Sales and marketing | (82) | 85 | (6) | 173 |
| General and administrative | 346 | 394 | 281 | 853 |
| Total | $324 | $716 | $(205) | $1,641 |
Comparison of the Three Months Ended September 30, 2025 and 2024
Revenue
(dollars in thousands)
| Three Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Product revenue | $35,368 | 56% | $39,278 | 55% | $(3,910) | (10)% |
| Service and subscription | 25,620 | 41% | 30,205 | 42% | (4,585) | (15)% |
| Royalty | 1,727 | 3% | 2,363 | 3% | (636) | (27)% |
| Total revenue | $62,715 | 100% | $71,846 | 100% | $(9,131) | (13)% |
Product Revenue
In the three months ended September 30, 2025, product revenue decreased $3.9 million, or 10%, as compared to the same period in fiscal 2025. The primary driver of the decrease was due to large orders in the prior period across secondary and primary storage.
Service and Subscription Revenue
Service and subscription revenue decreased $4.6 million, or 15%, in the three months ended September 30, 2025 compared to the same period in fiscal 2025. This decrease was due to certain long-lived products reaching their end-of-service-life.
Royalty Revenue
We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue decreased $0.6 million, or 27%, in the three months ended September 30, 2025 compared to the same period in fiscal 2025 due to both lower market volume and a mix weighted towards linear-tape-open (“LTO”) types with lower royalty rates.
Gross Profit and Margin
(dollars in thousands)
| Three Months Ended September 30, 2025 | Gross margin % | 2024 | Gross margin % | $ Change | Basis point change | |
|---|---|---|---|---|---|---|
| Product | $6,620 | 18.7% | $9,504 | 24.2% | $(2,884) | (550) |
| Service and subscription | 15,205 | 59.3% | 18,778 | 62.2% | (3,573) | (290) |
| Royalty | 1,727 | 100.0% | 2,363 | 100.0% | (636) | — |
| Gross profit | $23,552 | 37.6% | $30,645 | 42.7% | $(7,093) | (510) |
Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.
Product Gross Margin
Product gross margin decreased by $2.9 million, or by 550 basis points, for the three months ended September 30, 2025, as compared with the same period in fiscal 2025. This decrease was primarily due to an inventory provision accrued for certain end-of-life products, as well as an overall mix weighted towards lower margin products.
Service and Subscription Gross Margin
Service and subscription gross margins decreased 290 basis points for the three months ended September 30, 2025, as compared with the same period in fiscal 2025. This decrease was primarily driven by reduced revenue as many long-lived products reach their end-of-service life. To mitigate these declines, costs of service has been reduced across the organization, including logistics, repair, and labor.
Royalty Gross Margin
Royalties do not have significant related cost of sales.
Operating Expenses
(dollars in thousands)
| Three Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Sales and marketing | $11,819 | 19% | $13,578 | 19% | $(1,759) | (13)% |
| General and administrative | 11,006 | 18% | 13,977 | 19% | (2,971) | (21)% |
| Research and development | 5,692 | 9% | 8,264 | 12% | (2,572) | (31)% |
| Restructuring charges | 3,193 | 5% | 383 | 1% | 2,810 | 734% |
| Total operating expenses | $31,710 | 51% | $36,202 | 50% | $(4,492) | (12)% |
In the three months ended September 30, 2025, sales and marketing expenses decreased $1.8 million, or 13%, as compared with the same period in fiscal 2025. This decrease was primarily driven by improved operational efficiency and increased leverage of our channel.
In the three months ended September 30, 2025, general and administrative expenses decreased $3.0 million, or 21%, as compared with the same period in fiscal 2025. This decrease was primarily driven by higher expense in the prior year related to compliance focused outside services.
In the three months ended September 30, 2025, research and development expenses decreased $2.6 million, or 31%, as compared with the same period in fiscal 2025. This decrease was the result of efficiencies realized through improved organization design, including the consolidation of common functions and increased weighting of resources in lower-cost regions.
In the three months ended September 30, 2025, restructuring expenses increased $2.8 million, or 734% as compared with the same period in fiscal 2025. This increase in restructuring expenses primarily involves workforce reductions and related severance and termination benefits.These actions are part of management’s ongoing efforts to align the Company’s organizational structure and resources with its strategic priorities and to streamline operations across business units.
The Company expects these initiatives to result in future cost savings and productivity improvements beginning in fiscal 2026. The restructuring activities are expected to be substantially completed by the end of the fourth quarter of fiscal year 2026; however, the timing and total amount of charges are subject to change as implementation progresses.
Other Income (Expense), net
(dollars in thousands)
| Three Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Other income (expense),net | $(185) | 0% | $(1,334) | (2)% | $1,149 | 86% |
The change in other income (expense), net during the three months ended September 30, 2025 compared with the same period in fiscal 2025 was related primarily to fluctuations in foreign currency exchange rates during the three months ended September 30, 2025.
Interest Expense
(dollars in thousands)
| Three Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Interest expense | $(6,227) | (10)% | $(6,131) | (9)% | $(96) | 2% |
In the three months ended September 30, 2025, interest expense increased $0.1 million, or 2%, as compared with the same period in fiscal 2025 due to a higher effective interest rate on our Term Loan.
Warrant Liabilities
(dollars in thousands)
| Three Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Change in fair value of warrant liabilities | $1,525 | 2% | $3,550 | 6% | $(2,025) | (57)% |
In the three months ended September 30, 2025, we recorded a non-cash gain of $1.5 million related to the change in fair value of our Forbearance Warrant liabilities. In the three months ended September 30, 2024, we recorded a non-cash gain of $3.6 million.
Loss on Debt Extinguishment
(dollars in thousands)
| Three Months Ended June 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Loss on debt extinguishment | $(33,254) | (48)% | $(2,308) | (3)% | $(30,946) | 1,341% |
28
In September 30, 2025, loss on debt extinguishment was related to the net of discount on issuance of term loans to a new lender and write-off of all unamortized debt issuance costs and fees. In September 30, 2024, loss on debt extinguishment was related to prepayment of our long-term debt.
Income Taxes
(dollars in thousands)
| Three Months Ended September 30, 2025 | % of pretax income | 2024 | % of pretax income | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Income tax provision | $157 | —% | $370 | (3)% | $(213) | (58)% |
The income tax provision for the three months ended September 30, 2025 and 2024 is primarily influenced by foreign and state income taxes. Due to our history of net losses in the United States, the protracted period for utilizing tax attributes in certain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.
On July 4, 2025, President Trump signed the One Big Beautiful Bill Act (OBBBA), which includes various tax law changes effective beginning in 2025; while the Act had no material impact on the Company’s third-quarter 2025 results, the Company is evaluating its future effects.
Comparison of the Six Months Ended September 30, 2025 and 2024
Revenue
(dollars in thousands)
| Six Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Product revenue | $72,905 | 57% | $81,931 | 57% | $(9,026) | (11)% |
| Service and subscription | 50,563 | 40% | 56,915 | 39% | (6,352) | (11)% |
| Royalty | 3,534 | 3% | 5,265 | 4% | (1,731) | (33)% |
| Total revenue | $127,002 | 100% | $144,111 | 100% | $(17,109) | (12)% |
Product Revenue
In the six months ended September 30, 2025, product revenue decreased $$9.0 million, or 11%, as compared to the same period in fiscal 2025. The primary driver of the decrease was in Primary storage systems with a large video surveillance order in the prior period.
Service and Subscription Revenue
Service and subscription revenue decreased $6.4 million, or 11%, in the six months ended September 30, 2025 compared to the same period in fiscal 2025. This decrease was due to certain long-lived products reaching their end-of-service-life.
Royalty Revenue
We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue saw a decrease of $1.7 million, or 33%, in the six months ended September 30, 2025 compared to the same period in fiscal 2025 due to both lower market volume and a mix weighted towards LTO types with lower royalty rates.
Gross Profit and Margin
(dollars in thousands)
| Six Months Ended September 30, 2025 | Gross margin % | 2024 | Gross margin % | $ Change | Basis point change | |
|---|---|---|---|---|---|---|
| Product | $13,412 | 18.7% | $19,601 | 24.2% | $(6,189) | (550) |
| Service and subscription | 29,320 | 59.3% | 32,835 | 62.2% | (3,515) | (290) |
| Royalty | 3,534 | 100.0% | 5,265 | 100.0% | (1,731) | — |
| Gross profit | $46,266 | 37.6% | $57,701 | 42.7% | $(11,435) | (510) |
Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.
Product Gross Margin
Product gross margin decreased by $6.2 million, or by 550 basis points, for the six months ended September 30, 2025, as compared with the same period in fiscal 2025. This decrease was primarily due to an inventory provision accrued for certain end-of-life products, as well as supply chain logistics costs including import tariffs.
Service and Subscription Gross Margin
Service and subscription gross margins decreased (290) basis points for the six months ended September 30, 2025, as compared with the same period in fiscal 2025. This decrease was primarily driven by reduced revenue as many long-lived products reach their end-of-service life. To mitigate these declines, costs of service has been reduced across the organization, including logistics, repair, and labor.
Royalty Gross Margin
Royalties do not have significant related cost of sales.
Operating Expenses
(dollars in thousands)
| Six Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Sales and marketing | $24,474 | 39% | $26,873 | 37% | $(2,399) | (9)% |
| General and administrative | 24,576 | 39% | 35,042 | 49% | (10,466) | (30)% |
| Research and development | 12,353 | 20% | 16,572 | 23% | (4,219) | (25)% |
| Restructuring charges | 5,616 | 9% | 1,574 | 2% | 4,042 | 257% |
| Total operating expenses | $67,019 | 107% | $80,061 | 111% | $(13,042) | (16)% |
In the six months ended September 30, 2025, sales and marketing expenses decreased $2.4 million, or 9%, as compared with the same period in fiscal 2025. This decrease was primarily driven by improved operational efficiency and increased leverage of our channel.
In the six months ended September 30, 2025, general and administrative expenses decreased $10.5 million, or 30%, as compared with the same period in fiscal 2025. This decrease was primarily driven by higher expense in the prior year related to compliance focused outside services.
In the six months ended September 30, 2025, research and development expenses decreased $4.2 million, or 25%, as compared with the same period in fiscal 2025. This decrease was the result of efficiencies realized through improved organization design, including the consolidation of common functions and increased weighting of resources in lower-cost regions.
In the six months ended September 30, 2025, restructuring expenses increased $4.0 million, or 257% as compared with the same period in fiscal 2025. The increase was the result of significant changes in management structure, and overall consolidation of resources designed to improve operational efficiencies and rationalize its cost structure. These actions are part of management’s ongoing efforts to align the Company’s organizational structure and resources with its strategic priorities and to streamline operations across business units. The restructuring plan primarily involves workforce reductions and related severance and termination benefits.
The Company expects these initiatives to result in future cost savings and productivity improvements beginning in fiscal 2026. The restructuring activities are expected to be substantially completed by the end of the fourth quarter of fiscal year 2026; however, the timing and total amount of charges are subject to change as implementation progresses.
Other Income (Expense), net
(dollars in thousands)
| Six Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Other income (expense), net | $(616) | (1)% | $(1,375) | (2)% | $759 | 55% |
The change in other income (expense), net during the six months ended September 30, 2025 compared with the same period in fiscal 2025 was related primarily to fluctuations in foreign currency exchange rates during the three months ended September 30, 2025.
Interest Expense
(dollars in thousands)
| Six Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Interest expense | $(12,743) | (10)% | $(9,921) | (7)% | $(2,822) | 28% |
In the six months ended September 30, 2025, interest expense increased $0.1 million, or 2%, as compared with the same period in fiscal 2025 due to a higher effective interest rate on our Term Loan.
Warrant Liabilities
(dollars in thousands)
| Six Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Change in fair value of warrant liabilities | $1,525 | 1% | $5,216 | 4% | $(3,691) | (71)% |
In the six months ended September 30, 2025, we recorded a non-cash gain of $1.5 million related to the change in fair value of our Forebearance Warrant liabilities. In the six months ended September 30, 2024, we recorded a non-cash gain of $5.2 million.
Loss on Debt Extinguishment
(dollars in thousands)
| Six Months Ended September 30, 2025 | % of revenue | 2024 | % of revenue | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Loss on debt extinguishment | $(30,695) | (24)% | $(3,003) | (2)% | $(27,692) | 922% |
In September 30, 2025, loss on debt extinguishment was related to the net of discount on issuance of term loans to a new lender and write-off of all unamortized debt issuance costs and fees. In September 30, 2024, loss on debt extinguishment was related to prepayment of our long-term debt.
Income Taxes
(dollars in thousands)
| Six Months Ended September 30, 2025 | % of pretax income | 2024 | % of pretax income | $ Change | % Change | |
|---|---|---|---|---|---|---|
| Income tax provision | $380 | —% | $605 | (3)% | $(225) | (37)% |
31
The income tax provision for the six months ended September 30, 2025 and 2024 is primarily influenced by foreign and state income taxes. Due to our history of net losses in the United States, the protracted period for utilizing tax attributes in certain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.
On July 4, 2025, President Trump signed the One Big Beautiful Bill Act (OBBBA), which includes various tax law changes effective beginning in 2025; while the Act had no material impact on the Company’s third-quarter 2025 results, the Company is evaluating its future effects.
LIQUIDITY AND CAPITAL RESOURCES
We consider liquidity in terms of the sufficiency of internal and external cash resources to fund our operating, investing and financing activities. Our principal sources of liquidity include cash from operating activities, and cash and cash equivalents on our balance sheet. We require significant cash resources to meet obligations to pay principal and interest on our outstanding debt, provide for our research and development activities, fund our working capital needs, and make capital expenditures. Our future liquidity requirements will depend on multiple factors, including our ability to raise additional capital, research and development plans and capital asset needs.
We had cash and cash equivalents of $14.7 million as of September 30, 2025, which consisted primarily of bank deposits and money market accounts. As of September 30, 2025, our total outstanding Term Loan debt was $106.1 million.
We generated negative cash flows from operations of approximately $32.5 million and $17.2 million for the six months ended September 30, 2025 and 2024, respectively, and generated net losses of approximately $63.7 million and $32.0 million for the six months ended September 30, 2025 and 2024, respectively. We have funded operations through the sale of Common Stock, Term Loan borrowings and PNC Credit Facility borrowings described in Note 4: Debt.
On January 25, 2025, the Company entered into the SEPA, in which pursuant to and subject to its terms, the Company has the right, but not the obligation, to sell up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA. As of September 30, 2025, the Company has issued approximately 7.5 million shares of Common Stock under the SEPA for net proceeds of approximately $82.8 million, of which 6.3 million shares of Common Stock for net proceeds of approximately $66.9 million were issued in the six months ended September 30, 2025. No shares were issued in the three months ended September 30, 2025.
Our Term Loan has a maturity date of August 5, 2026. As discussed in Note 1: Description of Business and Summary of Significant Accounting Policies—Going Concern, we believe we will not be able to make the required repayment on that date using cash generated from operating activities. We entered into the Transaction Agreement that will convert Dialectic’s portion of the Term Loan into a Convertible Note with a three year maturity. We also agreed to use the proceeds from the SEPA to repay the OC III Lenders portion of the Term Loan. The issuance of the Convertible Note is subject to stockholder approval and there is no assurance that it will be approved. Also, we may not be able to access the SEPA to generate sufficient cash to repay OC III Lenders by the maturity date. We may be unable to obtain additional funding from other sources.
Cash Flows
The following table summarizes our condensed consolidated cash flows for the periods indicated.
(in thousands)
| Cash provided by (used in): | Six Months Ended September 30, 2025 | 2024 |
|---|---|---|
| Operating activities | $(32,489) | $(17,194) |
| Investing activities | (1,606) | (3,228) |
| Financing activities | 32,791 | 11,525 |
| Effect of exchange rate changes | 30 | (3) |
| Net decrease in cash, cash equivalents and restricted cash | $(1,274) | $(8,900) |
Cash Used In Operating Activities
Net cash used in operating activities was $32.5 million for the six months ended September 30, 2025. This use of cash was primarily attributed to lower earnings.
Net cash used in operating activities was $17.2 million for the six months ended September 30, 2024. This use of cash was primarily attributed to lower earnings.
Cash Used in Investing Activities
Net cash used in investing activities was $1.6 million in the six months ended September 30, 2025, which was attributable to capital expenditures.
Net cash used in investing activities was $3.2 million in the six months ended September 30, 2024, which was attributable to capital expenditures.
Cash Provided by Financing Activities
Net cash provided by financing activities was $32.8 million for the six months ended September 30, 2025, which was related primarily to borrowings on our Term Loan.
Net cash provided by financing activities was $11.5 million for the six months ended September 30, 2024, which was related primarily to proceeds from shares issued under the SEPA.
Commitments and Contingencies
Our contingent liabilities consist primarily of certain financial guarantees, both express and implied, related to product liability and potential infringement of intellectual property. We have little history of costs associated with such indemnification requirements and contingent liabilities associated with product liability may be mitigated by our insurance coverage. In the normal course of business to facilitate transactions of our services and products, we indemnify certain parties with respect to certain matters, such as intellectual property infringement or other claims. We also have indemnification agreements with our current and former officers and directors. It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of our indemnification claims, and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these agreements have not had a material impact on our operating results, financial position or cash flows.
We are also subject to ordinary course litigation. See Note 10: Commitments and Contingencies to the unaudited condensed consolidated financial statements for a discussion of our legal matters.
Off Balance Sheet Arrangements
Except for the indemnification commitments described under “Commitments and Contingencies” above, we do not currently have any other off-balance sheet arrangements and do not have any holdings in variable interest entities.
Contractual Obligations
We have contractual obligations and commercial commitments, some of which, such as purchase obligations, are not recognized as liabilities in our condensed consolidated financial statements. There have not been any material changes to the contractual obligations disclosed in the Annual Report.
Critical Accounting Estimates and Policies
The preparation of our consolidated financial statements in accordance with generally accepted accounting principles requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes included elsewhere in this Quarterly Report. On an ongoing basis, we evaluate estimates, which are based on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. We consider certain accounting policies to be critical to understanding our financial statements because the application of these policies requires significant judgment on the part of management, which could have a material impact on our financial statements if actual performance should differ from historical experience or if our assumptions were to change. Our accounting policies that include estimates that require management’s subjective or complex judgments about the effects of matters that are inherently uncertain are summarized in the Annual Report under the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates and Policies.” For additional information on our significant accounting policies, see Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.
Recently Issued and Adopted Accounting Pronouncements
See Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.
Market risk
As filed, 303 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to our quantitative and qualitative disclosures about market risk from those described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Annual Report, which such section is incorporated herein by reference.
Controls and procedures
As filed, 7,341 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive and principal financial officers, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)), as of the end of the period covered by this Quarterly Report. Based on such evaluation, our principal executive and principal financial officers have concluded that as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses described below.
Notwithstanding the identified material weaknesses, management, including our chief executive officer and principal financial officer have determined, that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly represent in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, for the periods presented in accordance with U.S. generally accepted accounting principles.
Material Weaknesses in Internal Control Over Financial Reporting
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.
Management did not adequately design and implement effective control activities resulting in the identification of the following material weaknesses:
Revenue Recognition
The Company did not maintain effective internal controls related to revenue recognition for the following:
- Controls related to the Company’s accounting practices and procedures for application of standalone selling price under Accounting Standards Codification Topic 606 *Revenue from Contracts with Customers (“*Topic 606”). Specifically, the Company did not have adequate controls in place to conclude on the application of standalone selling price consistent with the generally accepted application of the guidance in Topic 606.
- Controls over the accuracy of the inputs in the sales order entry process. Specifically, the Company did not sufficiently execute controls over the review of data inputs in the sales order entry process to ensure accuracy of the price, quantity, and related customer data.
- Controls for reviewing and updating deferral schedules, which drives the timing of service revenue recognition. Specifically, the start and end dates in the deferral schedules were not consistently aligned with the contractual service periods.
Manufacturing Inventory
The Company did not maintain effective internal controls related to manufacturing inventory. Specifically, controls to assess the accuracy of inventory held at third-party locations were not adequately executed.
Control Environment
Based on the material weaknesses identified in revenue recognition and manufacturing inventory, management concluded that the Company did not maintain effective entity-level controls within the control environment to prevent or detect material misstatements to the consolidated financial statements. Specifically, the Company (i) lacked sufficiently qualified staff or resources to perform control activities and (ii) conducted inadequate risk assessment and monitoring activities resulting in untimely or ineffective identification of internal control risks to support the design implementation and evaluation of the internal controls necessary to provide effective oversight over financial reporting.
Remediation Plan
The Company has implemented and is continuing to implement enhancements to address the identified material weaknesses. Actions include:
- Reviewing and updating relevant policies, procedures, and controls; this may include automation of certain controls within the ERP system where appropriate.
- Providing additional training to personnel responsible for executing and reviewing key controls.
- Enhancing efforts to assess risk and monitor the effectiveness of control design and operation over time.
- Engaging third-party specialists to assist the Company in assessing and establishing standalone selling price. While this has been completed, efforts are ongoing to increase automation in the calculation of standalone selling price.
- Engaging third-party specialists to help design and implement a control that reviews draft invoices above specified thresholds against customer purchase orders to assess the accuracy of the inputs in the sales order entry process prior to invoicing.
The Company is committed to maintaining a strong internal control environment and believes the remediation efforts will represent significant improvements in its controls over the control environment. These steps will take time to be fully implemented and confirmed to be effective and sustainable. Additional controls may also be required over time. While the Company believes that these efforts will improve its internal control over financial reporting, the Company will not be able to conclude whether the steps the Company is taking will remediate the material weaknesses in internal control over financial reporting until a sufficient period has passed to allow management to test the design and operational effectiveness of the new and enhanced controls. Until the remediation steps set forth above are fully implemented and tested, the material weaknesses will continue to exist.
Changes in Internal Control
During the quarter ended September 30, 2025, Lewis Moorehead resigned as CFO effective August 18, 2025 and Laura Nash was appointed principal financial officer in his place. Except for the ongoing remediation measures to address the material weaknesses, in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act, there were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls
Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Risk factors
As filed, 426 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the previously disclosed risk factors discussed in “Part I, Item 1A, Risk Factors” in the Annual Report. You should consider carefully these factors, together with all of the other information in this Quarterly Report, including our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, before making an investment decision.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $62.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2025-04-01 to 2025-09-30 | $127.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-07-01 to 2025-09-30 | $39.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-04-01 to 2025-09-30 | $80.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-07-01 to 2025-09-30 | $23.6m | us-gaap:GrossProfit |
| Gross profit | 6 months2025-04-01 to 2025-09-30 | $46.3m | us-gaap:GrossProfit |
| Research and development | 3 months2025-07-01 to 2025-09-30 | $5.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2025-04-01 to 2025-09-30 | $12.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-07-01 to 2025-09-30 | −$8.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-04-01 to 2025-09-30 | −$20.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-07-01 to 2025-09-30 | $6.2m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2025-04-01 to 2025-09-30 | $12.7m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $157.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-04-01 to 2025-09-30 | $380.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | −$46.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-04-01 to 2025-09-30 | −$63.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | −$3.49 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-04-01 to 2025-09-30 | −$5.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | −$3.49 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-04-01 to 2025-09-30 | −$5.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 13,322,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-04-01 to 2025-09-30 | 11,266,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-04-01 to 2025-09-30 | −$32.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-04-01 to 2025-09-30 | $1.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-09-30 | $14.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-09-30 | $90.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-09-30 | $137.7m | us-gaap:Assets |
| Current liabilities | At period end2025-09-30 | $241.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-09-30 | $298.2m | us-gaap:Liabilities |
| Long-term debt | At period end2025-09-30 | $0 | us-gaap:LongTermDebt |
| Current portion of debt | At period end2025-09-30 | $99.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-09-30 | −$160.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000709283-25-000085. Last ingested by Listed: Nov 6, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.